Table 1 Baseline characteristics of the included patients according to NLR tertiles
1st tertile ≤ 3.37 (n = 245) | 2nd tertile 3.38–6.93 (n = 245) | 3rd tertile ≥ 6.94 (n = 247) | t/Z/χ2 | P | |
|---|---|---|---|---|---|
Sex (male/female) | 200/45 | 203/42 | 213/34 | 2.039 | 0.361 |
Age (years) | 58.20 ± 12.46 | 57.20 ± 12.45 | 58.64 ± 12.04 | 0.877 | 0.417 |
Hypertension | 113 (46.1) | 115 (46.9) | 103 (41.7) | 1.582 | 0.453 |
Diabetes mellitus | 76 (31.0) | 64 (26.1) | 53 (21.5) | 5.820 | 0.054 |
DM treatment | 3.808 | 0.433 | |||
Diet only | 4 (6.6) | 2 (3.6) | 2 (4.9) | ||
Oral hypoglycemic drugs | 23 (37.7) | 30 (54.5) | 21 (51.2) | ||
Insulin | 34 (55.7) | 23 (41.8) | 18 (43.9) | ||
Smoking | 9.319 | 0.054 | |||
Never smoker | 110 (44.9) | 132 (53.9) | 115 (46.6) | ||
Former smoker | 19 (7.8) | 7 (2.9) | 11 (4.5) | ||
Current smoker | 116 (47.3) | 106 (43.3) | 121 (49.0) | ||
Alcohol drinking | 2.390 | 0.664 | |||
Never drinking | 151 (61.9) | 149 (61.3) | 146 (59.3) | ||
Former drinking | 35 (14.3) | 35 (14.4) | 46 (18.7) | ||
Current drinking | 58 (23.8) | 59 (24.3) | 54 (22.0) | ||
Family history of CAD | 99 (40.4) | 101 (41.2) | 97 (39.3) | 0.197 | 0.906 |
SBP (mmHg) | 122.02 ± 20.97 | 122.91 ± 19.32 | 122.21 ± 19.17 | 0.137 | 0.872 |
DBP (mmHg) | 75.96 ± 13.59 | 76.75 ± 12.90 | 77.23 ± 13.84 | 0.567 | 0.567 |
Heart rate (bpm) | 82.78 ± 15.31 | 80.54 ± 14.71 | 82.50 ± 15.03 | 1.618 | 0.199 |
BMI (kg/m2) | 25.11 ± 5.28 | 25.04 ± 5.15 | 24.63 ± 5.94 | 0.475 | 0.622 |
HDL-C (mmol/l) | 0.95 ± 0.26 | 1.00 ± 0.26 | 1.01 ± 0.26 | 2.575 | 0.077 |
LDL-C (mmol/l) | 2.93 ± 0.91 | 2.96 ± 0.84 | 2.97 ± 0.85 | 0.095 | 0.910 |
TC (mmol/l) | 4.61 ± 1.22 | 4.66 ± 1.26 | 4.59 ± 1.08 | 0.181 | 0.834 |
TG (mmol/l) | 1.76 ± 1.13 | 2.04 ± 1.06a | 2.26 ± 1.17ab | 11.988 | < 0.001 |
ApoA1 (g/L) | 1.21 ± 0.29 | 1.28 ± 0.53 | 1.22 ± 0.27 | 1.604 | 0.202 |
ApoB (g/L) | 0.92 ± 0.49 | 0.90 ± 0.27 | 0.91 ± 0.26 | 0.160 | 0.852 |
Lp (a) (g/L) | 244.88 ± 258.72 | 236.56 ± 227 | 239.63 ± 214.2 | 0.059 | 0.942 |
Creatinine (mmol/L) | 79.27 ± 36.5 | 81.75 ± 56.31 | 79.25 ± 35.77 | 0.259 | 0.772 |
BUN (mmol/l) | 5.42 ± 2.76 | 5.69 ± 2.26 | 5.68 ± 2.81 | 0.833 | 0.435 |
Uric acid (mmol/L) | 334.27 ± 90.96 | 326.4 ± 88.92 | 325.73 ± 99.45 | 0.629 | 0.534 |
WBC | 9.03 ± 3.21 | 11.05 ± 3.35a | 12.32 ± 3.41ab | 61.212 | < 0.001 |
Monocyte count | 0.63 ± 0.24 | 0.66 ± 0.34 | 0.46 ± 0.32ab | 30.768 | < 0.001 |
PLR | 89.94 ± 36.52 | 145.34 ± 110.94a | 265.13 ± 175.65ab | 132.705 | < 0.001 |
RBC | 4.77 ± 0.72 | 4.85 ± 0.58 | 4.65 ± 0.82b | 4.852 | 0.008 |
HGB | 145.04 ± 22.16 | 144.99 ± 26.14 | 142.53 ± 28.78 | 0.759 | 0.468 |
PLT | 224.49 ± 71.94 | 229.48 ± 144.24 | 236.26 ± 162.19 | 0.492 | 0.612 |
MPV | 10.16 ± 1.43 | 10.26 ± 1.24 | 10.14 ± 1.66 | 0.499 | 0.608 |
PDW | 13.36 ± 3.83 | 13.43 ± 3.71 | 13.31 ± 3.22 | 0.065 | 0.937 |
PCT | 0.24 ± 0.08 | 0.23 ± 0.09 | 0.25 ± 0.12 | 1.632 | 0.196 |
Clinical diagnosis | 20.160 | < 0.001 | |||
UA | 52 (21.2) | 29 (11.8) | 19 (7.7) | ||
NSTEMI | 26 (10.7) | 30 (12.2) | 31 (12.6) | ||
STEMI | 167 (68.2) | 186 (75.9) | 197 (79.8) | ||
Coronary artery lesion | |||||
UPLMT | 22 (9.2) | 25 (10.6) | 21 (8.7) | 0.526 | 0.769 |
LAD | 217 (88.9) | 211 (86.5) | 216 (87.8) | 0.687 | 0.709 |
LCX | 155 (64.3) | 147 (61.0) | 155 (63.0) | 0.577 | 0.749 |
RCA | 179 (74.0) | 178 (73.3) | 186 (75.3) | 0.278 | 0.870 |
Medication situation | |||||
Aspirin | 20 (8.2) | 32 (13.1) | 22 (8.9) | 3.782 | 0.151 |
Statins | 18 (7.3) | 28 (11.4) | 21 (8.5) | 2.625 | 0.269 |
β-Blockers | 16 (6.5) | 16 (6.5) | 12 (4.9) | 0.818 | 0.664 |
ACEI/ARB | 8 (3.3) | 13 (5.3) | 6 (2.4) | 3.049 | 0.218 |
CCB | 41 (16.7) | 26 (10.6) | 35 (14.2) | 3.885 | 0.143 |